Huizhen Suo

1.1k total citations · 1 hit paper
7 papers, 730 citations indexed

About

Huizhen Suo is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Huizhen Suo has authored 7 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Huizhen Suo's work include Cancer Research and Treatments (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Enzyme-mediated dye degradation (1 paper). Huizhen Suo is often cited by papers focused on Cancer Research and Treatments (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Enzyme-mediated dye degradation (1 paper). Huizhen Suo collaborates with scholars based in Germany, Ukraine and Sweden. Huizhen Suo's co-authors include Tetyana Yevsa, Stephan Fricke, Alexander Strauß, Uta Kossatz-Boehlert, André‐René Blaudszun, Lia Walcher, Reni Kitte, Michael P. Manns, Mikael E. Lindström and Lavinia Neubert and has published in prestigious journals such as Oncogene, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Huizhen Suo

7 papers receiving 718 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies

2020 662 citations Lia Walcher, Huizhen Suo et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huizhen Suo Germany	5	398	328	239	101	86	7	730
Lia Walcher Germany	5	395 1.0×	317 1.0×	234 1.0×	94 0.9×	70 0.8×	5	717
Xuli Meng China	14	489 1.2×	257 0.8×	220 0.9×	128 1.3×	87 1.0×	43	792
Ramesh Butti India	12	545 1.4×	352 1.1×	315 1.3×	113 1.1×	55 0.6×	19	921
Nayoung Jun South Korea	4	607 1.5×	440 1.3×	267 1.1×	81 0.8×	87 1.0×	7	919
Sanghyun Lee South Korea	5	610 1.5×	439 1.3×	266 1.1×	82 0.8×	87 1.0×	6	923
Hai Yang Germany	12	509 1.3×	359 1.1×	289 1.2×	69 0.7×	59 0.7×	15	799
Hanna Dillekås Norway	4	308 0.8×	294 0.9×	221 0.9×	93 0.9×	90 1.0×	6	702
Monica Cojoc Germany	10	487 1.2×	434 1.3×	330 1.4×	71 0.7×	71 0.8×	11	930
Yeonhwa Song South Korea	16	343 0.9×	297 0.9×	184 0.8×	56 0.6×	104 1.2×	25	699
Said M. Afify Japan	15	438 1.1×	364 1.1×	165 0.7×	91 0.9×	107 1.2×	40	730

Countries citing papers authored by Huizhen Suo

Since Specialization

Citations

This map shows the geographic impact of Huizhen Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huizhen Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huizhen Suo more than expected).

Fields of papers citing papers by Huizhen Suo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huizhen Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huizhen Suo. The network helps show where Huizhen Suo may publish in the future.

Co-authorship network of co-authors of Huizhen Suo

This figure shows the co-authorship network connecting the top 25 collaborators of Huizhen Suo. A scholar is included among the top collaborators of Huizhen Suo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huizhen Suo. Huizhen Suo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Suo, Huizhen, et al.. (2024). Lactiplantibacillus plantarum inhibited the growth of primary liver cancer by inducing early apoptosis and senescence, in vitro. Frontiers in Microbiology. 15. 1451170–1451170. 4 indexed citations

2.

Suo, Huizhen, Kai Timrott, Lavinia Neubert, et al.. (2024). Essential roles of B cell subsets in the progression of MASLD and HCC. JHEP Reports. 6(12). 101189–101189. 4 indexed citations

3.

Pylypchuk, Ievgen V., Huizhen Suo, Pär A. Lindén, et al.. (2022). High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer. Frontiers in Bioengineering and Biotechnology. 9. 817768–817768. 21 indexed citations

4.

Suo, Huizhen, et al.. (2022). Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro. Frontiers in Pharmacology. 13. 906468–906468. 7 indexed citations

5.

Hoenicke, Lisa, Lavinia Neubert, Juan Carlos López Alfonso, et al.. (2022). Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers. Oncogene. 41(14). 2039–2053. 18 indexed citations

6.

Neubert, Lavinia, Kai Timrott, Huizhen Suo, et al.. (2021). Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. OncoImmunology. 10(1). 1874159–1874159. 14 indexed citations

7.

Walcher, Lia, Huizhen Suo, Reni Kitte, et al.. (2020). Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology. 11. 1280–1280. 662 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact